Prelude Therapeutics Inc

NASDAQ:PRLD  
47.04
+1.69 (+3.73%)
Earnings Announcements

Prelude Therapeutics Announces Third Quarter 2020 Financial Results

Published: 11/10/2020 13:13 GMT
(PRLD) - Prelude Therapeutics Announces Third Quarter 2020 Financial Results.
Q3 Loss per Share $5.25.
Q3 Earnings per Share Estimate $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.